Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other hematologic neoplasm 1 Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cisplatin 108 Radiotherapy 45 Docetaxel 44 Radiotherapy, Intensity-Modulated 36 Gemcitabine 31 Fluorouracil 30 camrelizumab 24 toripalimab 21 Drug Therapy 21 Cetuximab 20 apatinib 19 Paclitaxel 16 Carboplatin 16 pembrolizumab 14 Chemoradiotherapy 14 Capecitabine 13 Blood Specimen Collection 13 sintilimab 12 nimotuzumab 12 Surveys and Questionnaires 10 Surgical Procedures, Operative 10 Endostatins 10 Cyclophosphamide 9 nedaplatin 8 endostar protein 8 durvalumab 8 Nivolumab 8 Neoadjuvant Therapy 8 Induction Chemotherapy 8 fludarabine 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × monalizumab × Head & Neck × Clear all

NCT03088059 2023-11-03

UPSTREAM

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡